Investment Summary |
|
|---|---|
| Date | 2025-09-04 |
| Target | MRM Health |
| Sector | Life Science |
| Investor(s) | Biocodex USA |
| Deal Type | Stake Purchase |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1953 |
| Sector | Life Science |
Biocodex USA is an independent multinational pharmaceutical company, dedicated to providing its customers with meaningful health care solutions, with an emphasis on gastroenterology and oncology supportive care.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 4 |
| Sector: Life Science M&A | 4 of 4 |
| Type: Stake Purchase M&A Deals | 1 of 1 |
| Country: Belgium M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-11-17 |
Hilma
New York, New York, United States Hilma makes natural remedies that actually work for health issues like digestion, head tension, immune support, and more. The company makes natural remedies accessible to the mainstream customer, who has embraced natural products in food, beauty, and household items, and is looking for an effective natural option for their medicine cabinet. Hilma is entirely female-founded and led. Hilma was formed in 2020 and is based in New York, New York. |
Buy | - |
